ETHZilla Emerges: 180 Life Sciences Bets Big on Ethereum in $425M Pivot
180 Life Sciences is rebranding to ETHZilla with a $425M Ethereum strategy, aiming to dominate the corporate crypto treasury space.
In one of the boldest pivots yet in corporate finance, 180 Life Sciences is transforming from a biotech firm into a blockchain treasury powerhouse. The company, headquartered in Palo Alto, has announced a $425 million private placement aimed at converting nearly its entire balance sheet into Ethereum and rebranding as ETHZilla.
The transaction, backed by a high-profile consortium including Electric Capital, Polychain, and founders from Lido, Eigenlayer, and Compound, is expected to close by August 1. If finalized, ETHZilla would become one of the largest corporate holders of Ethereum, shifting its mission from anti-inflammatory therapeutics to actively managing digital assets in the DeFi ecosystem.
This isn’t a simple bet on price appreciation. ETHZilla's thesis is fundamentally different from Bitcoin-focused treasury models. While firms like MicroStrategy aim to accumulate and hold, ETHZilla is building an operational treasury designed to generate yield and support Ethereum's infrastructure.
Electric Capital will lead asset management, deploying ETH across staking protocols for base returns, liquidity pools for trading efficiency, and private lending deals that offer potential alpha. The strategy echoes an increasingly common sentiment among crypto-native investors: Ethereum isn’t just digital gold—it’s programmable capital.
“We believe this strategy reflects a long-term, institutional-grade approach to blockchain investment,” said Blair Jordan, CEO of 180 Life Sciences. “Our plan offers public market investors a transparent, actively managed entry into Ethereum’s growth story.”
More than 60 investors have joined the PIPE round, reinforcing industry confidence in the ETHZilla vision. Among them: Konstantin Lomashuk (Lido), Sreeram Kannan (Eigenlayer), and Robert Leshner (Compound). Their involvement signals that ETHZilla isn’t merely a treasury experiment—it’s a blueprint for how public companies can become full participants in decentralized finance.
ETHZilla’s emergence comes amid a surge in corporate interest in Ethereum. According to a report from Standard Chartered, firms have accumulated over 1.26 million ETH since June—roughly 1% of supply. Analysts project that figure could rise tenfold, with companies like BitMine and SharpLink Gaming also racing to increase their ETH holdings.
However, the model is not without risks. Yield-generating strategies in DeFi must contend with smart contract vulnerabilities, market volatility, and an evolving regulatory landscape. Yet ETHZilla is positioning itself to take on these challenges with institutional rigor.
If the transition succeeds, ETHZilla could serve as a transformative case study—showing that public companies can move beyond passive crypto exposure and become foundational actors in the on-chain economy.
